These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38212795)

  • 41. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
    Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
    J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
    BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CircAHNAK upregulates EIF2B5 expression to inhibit the progression of ovarian cancer by modulating the JAK2/STAT3 signaling pathway.
    He SL; Zhao X; Yi SJ
    Carcinogenesis; 2022 Nov; 43(10):941-955. PubMed ID: 35710311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis.
    Lu T; Wu B; Yu Y; Zhu W; Zhang S; Zhang Y; Guo J; Deng N
    Cancer Sci; 2018 Jul; 109(7):2221-2234. PubMed ID: 29737581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Farrerol inhibited angiogenesis through Akt/mTOR, Erk and Jak2/Stat3 signal pathway.
    Dai F; Gao L; Zhao Y; Wang C; Xie S
    Phytomedicine; 2016 Jun; 23(7):686-93. PubMed ID: 27235707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
    Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
    Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway.
    Fogg KC; Olson WR; Miller JN; Khan A; Renner C; Hale I; Weisman PS; Kreeger PK
    Cancer Lett; 2019 Aug; 458():92-101. PubMed ID: 31129149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient Prognosis.
    Lu X; Li R; Wang X; Guo Q; Wang L; Zhou X
    Cancer Biother Radiopharm; 2022 Nov; 37(9):850-861. PubMed ID: 34495766
    [No Abstract]   [Full Text] [Related]  

  • 49. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
    He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
    Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
    Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
    Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
    Li J; Yang D; Zhang C; Wei S; Zhao R; Dai S; Shan B
    Biomed Res Int; 2022; 2022():5328192. PubMed ID: 35937390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway.
    Chen M; Zeng J; Chen S; Li J; Wu H; Dong X; Lei Y; Zhi X; Yao L
    Aging (Albany NY); 2020 Jun; 12(11):10896-10911. PubMed ID: 32516133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
    Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MUC16 facilitates cervical cancer progression via JAK2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression.
    Shen H; Guo M; Wang L; Cui X
    Genes Genomics; 2020 Feb; 42(2):127-133. PubMed ID: 31736008
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
    Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
    Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR-518a-3p/TRIM44 axis.
    Ye H; Wang RY; Yu XZ; Wu YK; Yang BW; Ao MY; Xi MR; Hou MM
    Kaohsiung J Med Sci; 2023 Jan; 39(1):26-39. PubMed ID: 36448712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
    Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
    Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
    Bajwa P; Kordylewicz K; Bilecz A; Lastra RR; Wroblewski K; Rinkevich Y; Lengyel E; Kenny HA
    JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.